0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Human Cytomegalovirus Envelope Glycoprotein B Market Research Report 2024
Published Date: January 2024
|
Report Code: QYRE-Auto-4G10102
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Human Cytomegalovirus Envelope Glycoprotein B Market Insights Forecast to 2028
BUY CHAPTERS

Global Human Cytomegalovirus Envelope Glycoprotein B Market Research Report 2024

Code: QYRE-Auto-4G10102
Report
January 2024
Pages:77
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Human Cytomegalovirus Envelope Glycoprotein B Market

The global Human Cytomegalovirus Envelope Glycoprotein B market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Human Cytomegalovirus Envelope Glycoprotein B is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Human Cytomegalovirus Envelope Glycoprotein B include Astellas Pharma Inc., Trellis Bioscience, Inc., Vakzine Projekt Management GmbH, VBI Vaccine Inc and Vical Incorporated, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Human Cytomegalovirus Envelope Glycoprotein B, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Cytomegalovirus Envelope Glycoprotein B.

Report Scope

The Human Cytomegalovirus Envelope Glycoprotein B market size, estimations, and forecasts are provided in terms of sales volume (K Pcs) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Human Cytomegalovirus Envelope Glycoprotein B market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Human Cytomegalovirus Envelope Glycoprotein B manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Human Cytomegalovirus Envelope Glycoprotein B Market Report

Report Metric Details
Report Name Human Cytomegalovirus Envelope Glycoprotein B Market
Segment by Type
  • CSJ-148
  • CyMVectin
  • TRL-345
  • PPCM
  • Cytomegalovirus Vaccine
  • Others
Segment by Application
  • Infectious Disease
  • Oncology
  • Women's Health
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Astellas Pharma Inc., Trellis Bioscience, Inc., Vakzine Projekt Management GmbH, VBI Vaccine Inc, Vical Incorporated
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Human Cytomegalovirus Envelope Glycoprotein B manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Human Cytomegalovirus Envelope Glycoprotein B in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Human Cytomegalovirus Envelope Glycoprotein B Market report?

Ans: The main players in the Human Cytomegalovirus Envelope Glycoprotein B Market are Astellas Pharma Inc., Trellis Bioscience, Inc., Vakzine Projekt Management GmbH, VBI Vaccine Inc, Vical Incorporated

What are the Application segmentation covered in the Human Cytomegalovirus Envelope Glycoprotein B Market report?

Ans: The Applications covered in the Human Cytomegalovirus Envelope Glycoprotein B Market report are Infectious Disease, Oncology, Women's Health, Others

What are the Type segmentation covered in the Human Cytomegalovirus Envelope Glycoprotein B Market report?

Ans: The Types covered in the Human Cytomegalovirus Envelope Glycoprotein B Market report are CSJ-148, CyMVectin, TRL-345, PPCM, Cytomegalovirus Vaccine, Others

1 Human Cytomegalovirus Envelope Glycoprotein B Market Overview
1.1 Product Overview and Scope of Human Cytomegalovirus Envelope Glycoprotein B
1.2 Human Cytomegalovirus Envelope Glycoprotein B Segment by Type
1.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Value Comparison by Type (2024-2030)
1.2.2 CSJ-148
1.2.3 CyMVectin
1.2.4 TRL-345
1.2.5 PPCM
1.2.6 Cytomegalovirus Vaccine
1.2.7 Others
1.3 Human Cytomegalovirus Envelope Glycoprotein B Segment by Application
1.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Value by Application: (2024-2030)
1.3.2 Infectious Disease
1.3.3 Oncology
1.3.4 Women's Health
1.3.5 Others
1.4 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size Estimates and Forecasts
1.4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue 2019-2030
1.4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales 2019-2030
1.4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Human Cytomegalovirus Envelope Glycoprotein B Market Competition by Manufacturers
2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturers (2019-2024)
2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Average Price by Manufacturers (2019-2024)
2.4 Global Human Cytomegalovirus Envelope Glycoprotein B Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Product Type & Application
2.7 Human Cytomegalovirus Envelope Glycoprotein B Market Competitive Situation and Trends
2.7.1 Human Cytomegalovirus Envelope Glycoprotein B Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Cytomegalovirus Envelope Glycoprotein B Players Market Share by Revenue
2.7.3 Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Cytomegalovirus Envelope Glycoprotein B Retrospective Market Scenario by Region
3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region: 2019-2030
3.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region: 2019-2024
3.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region: 2025-2030
3.3 Global Human Cytomegalovirus Envelope Glycoprotein B Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2019-2030
3.3.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2019-2024
3.3.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2025-2030
3.4 North America Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.4.1 North America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2030)
3.4.3 North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.5.1 Europe Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2030)
3.5.3 Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.6.1 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2030)
3.6.3 Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.7.1 Latin America Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2030)
3.7.3 Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2030)
3.8.3 Middle East and Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2030)
4.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2019-2024)
4.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Type (2025-2030)
4.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2030)
4.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2019-2030)
4.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2019-2024)
4.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Type (2025-2030)
4.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2019-2030)
4.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Type (2019-2030)
5 Segment by Application
5.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2030)
5.1.1 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2019-2024)
5.1.2 Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Application (2025-2030)
5.1.3 Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2030)
5.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2019-2030)
5.2.1 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2019-2024)
5.2.2 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Application (2025-2030)
5.2.3 Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2019-2030)
5.3 Global Human Cytomegalovirus Envelope Glycoprotein B Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Astellas Pharma Inc.
6.1.1 Astellas Pharma Inc. Corporation Information
6.1.2 Astellas Pharma Inc. Description and Business Overview
6.1.3 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.1.5 Astellas Pharma Inc. Recent Developments/Updates
6.2 Trellis Bioscience, Inc.
6.2.1 Trellis Bioscience, Inc. Corporation Information
6.2.2 Trellis Bioscience, Inc. Description and Business Overview
6.2.3 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.2.5 Trellis Bioscience, Inc. Recent Developments/Updates
6.3 Vakzine Projekt Management GmbH
6.3.1 Vakzine Projekt Management GmbH Corporation Information
6.3.2 Vakzine Projekt Management GmbH Description and Business Overview
6.3.3 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.3.5 Vakzine Projekt Management GmbH Recent Developments/Updates
6.4 VBI Vaccine Inc
6.4.1 VBI Vaccine Inc Corporation Information
6.4.2 VBI Vaccine Inc Description and Business Overview
6.4.3 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2019-2024)
6.4.4 VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.4.5 VBI Vaccine Inc Recent Developments/Updates
6.5 Vical Incorporated
6.5.1 Vical Incorporated Corporation Information
6.5.2 Vical Incorporated Description and Business Overview
6.5.3 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product Portfolio
6.5.5 Vical Incorporated Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Chain Analysis
7.2 Human Cytomegalovirus Envelope Glycoprotein B Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Cytomegalovirus Envelope Glycoprotein B Production Mode & Process
7.4 Human Cytomegalovirus Envelope Glycoprotein B Sales and Marketing
7.4.1 Human Cytomegalovirus Envelope Glycoprotein B Sales Channels
7.4.2 Human Cytomegalovirus Envelope Glycoprotein B Distributors
7.5 Human Cytomegalovirus Envelope Glycoprotein B Customers
8 Human Cytomegalovirus Envelope Glycoprotein B Market Dynamics
8.1 Human Cytomegalovirus Envelope Glycoprotein B Industry Trends
8.2 Human Cytomegalovirus Envelope Glycoprotein B Market Drivers
8.3 Human Cytomegalovirus Envelope Glycoprotein B Market Challenges
8.4 Human Cytomegalovirus Envelope Glycoprotein B Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
    Table 1. Global Human Cytomegalovirus Envelope Glycoprotein B Market Value Comparison by Type (2024-2030) & (US$ Million)
    Table 2. Global Human Cytomegalovirus Envelope Glycoprotein B Market Value Comparison by Application (2024-2030) & (US$ Million)
    Table 3. Global Human Cytomegalovirus Envelope Glycoprotein B Market Competitive Situation by Manufacturers in 2023
    Table 4. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) of Key Manufacturers (2019-2024)
    Table 5. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Manufacturers (2019-2024)
    Table 6. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Manufacturers (2019-2024)
    Table 7. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers (2019-2024)
    Table 8. Global Market Human Cytomegalovirus Envelope Glycoprotein B Average Price (USD/Pcs) of Key Manufacturers (2019-2024)
    Table 9. Global Key Players of Human Cytomegalovirus Envelope Glycoprotein B, Industry Ranking, 2022 VS 2023 VS 2024
    Table 10. Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Manufacturing Sites & Headquarters
    Table 11. Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Product Type & Application
    Table 12. Global Key Manufacturers of Human Cytomegalovirus Envelope Glycoprotein B, Date of Enter into This Industry
    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Human Cytomegalovirus Envelope Glycoprotein B by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Cytomegalovirus Envelope Glycoprotein B as of 2023)
    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 16. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 17. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2019-2024) & (K Pcs)
    Table 18. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2019-2024)
    Table 19. Global Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2025-2030) & (K Pcs)
    Table 20. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2025-2030)
    Table 21. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2019-2024) & (US$ Million)
    Table 22. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2019-2024)
    Table 23. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2025-2030) & (US$ Million)
    Table 24. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2025-2030)
    Table 25. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 26. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024) & (K Pcs)
    Table 27. North America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2025-2030) & (K Pcs)
    Table 28. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024) & (US$ Million)
    Table 29. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2025-2030) & (US$ Million)
    Table 30. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 31. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024) & (K Pcs)
    Table 32. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2025-2030) & (K Pcs)
    Table 33. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024) & (US$ Million)
    Table 34. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2025-2030) & (US$ Million)
    Table 35. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 36. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2019-2024) & (K Pcs)
    Table 37. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales by Region (2025-2030) & (K Pcs)
    Table 38. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2019-2024) & (US$ Million)
    Table 39. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024) & (K Pcs)
    Table 42. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2025-2030) & (K Pcs)
    Table 43. Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024) & (US$ Million)
    Table 44. Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2025-2030) & (US$ Million)
    Table 45. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 46. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2019-2024) & (K Pcs)
    Table 47. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales by Country (2025-2030) & (K Pcs)
    Table 48. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2019-2024) & (US$ Million)
    Table 49. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue by Country (2025-2030) & (US$ Million)
    Table 50. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2019-2024)
    Table 51. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Type (2025-2030)
    Table 52. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2019-2024)
    Table 53. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Type (2025-2030)
    Table 54. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Type (2019-2024)
    Table 55. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Type (2025-2030)
    Table 56. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2019-2024)
    Table 57. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Type (2025-2030)
    Table 58. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) by Type (2019-2024)
    Table 59. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) by Type (2025-2030)
    Table 60. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2019-2024)
    Table 61. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs) by Application (2025-2030)
    Table 62. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2019-2024)
    Table 63. Global Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Application (2025-2030)
    Table 64. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Application (2019-2024)
    Table 65. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue (US$ Million) by Application (2025-2030)
    Table 66. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2019-2024)
    Table 67. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Application (2025-2030)
    Table 68. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) by Application (2019-2024)
    Table 69. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) by Application (2025-2030)
    Table 70. Astellas Pharma Inc. Corporation Information
    Table 71. Astellas Pharma Inc. Description and Business Overview
    Table 72. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 73. Astellas Pharma Inc. Human Cytomegalovirus Envelope Glycoprotein B Product
    Table 74. Astellas Pharma Inc. Recent Developments/Updates
    Table 75. Trellis Bioscience, Inc. Corporation Information
    Table 76. Trellis Bioscience, Inc. Description and Business Overview
    Table 77. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 78. Trellis Bioscience, Inc. Human Cytomegalovirus Envelope Glycoprotein B Product
    Table 79. Trellis Bioscience, Inc. Recent Developments/Updates
    Table 80. Vakzine Projekt Management GmbH Corporation Information
    Table 81. Vakzine Projekt Management GmbH Description and Business Overview
    Table 82. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 83. Vakzine Projekt Management GmbH Human Cytomegalovirus Envelope Glycoprotein B Product
    Table 84. Vakzine Projekt Management GmbH Recent Developments/Updates
    Table 85. VBI Vaccine Inc Corporation Information
    Table 86. VBI Vaccine Inc Description and Business Overview
    Table 87. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 88. VBI Vaccine Inc Human Cytomegalovirus Envelope Glycoprotein B Product
    Table 89. VBI Vaccine Inc Recent Developments/Updates
    Table 90. Vical Incorporated Corporation Information
    Table 91. Vical Incorporated Description and Business Overview
    Table 92. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2019-2024)
    Table 93. Vical Incorporated Human Cytomegalovirus Envelope Glycoprotein B Product
    Table 94. Vical Incorporated Recent Developments/Updates
    Table 95. Key Raw Materials Lists
    Table 96. Raw Materials Key Suppliers Lists
    Table 97. Human Cytomegalovirus Envelope Glycoprotein B Distributors List
    Table 98. Human Cytomegalovirus Envelope Glycoprotein B Customers List
    Table 99. Human Cytomegalovirus Envelope Glycoprotein B Market Trends
    Table 100. Human Cytomegalovirus Envelope Glycoprotein B Market Drivers
    Table 101. Human Cytomegalovirus Envelope Glycoprotein B Market Challenges
    Table 102. Human Cytomegalovirus Envelope Glycoprotein B Market Restraints
    Table 103. Research Programs/Design for This Report
    Table 104. Key Data Information from Secondary Sources
    Table 105. Key Data Information from Primary Sources
List of Figures
    Figure 1. Product Picture of Human Cytomegalovirus Envelope Glycoprotein B
    Figure 2. Global Human Cytomegalovirus Envelope Glycoprotein B Market Value Comparison by Type (2024-2030) & (US$ Million)
    Figure 3. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Type in 2023 & 2030
    Figure 4. CSJ-148 Product Picture
    Figure 5. CyMVectin Product Picture
    Figure 6. TRL-345 Product Picture
    Figure 7. PPCM Product Picture
    Figure 8. Cytomegalovirus Vaccine Product Picture
    Figure 9. Others Product Picture
    Figure 10. Global Human Cytomegalovirus Envelope Glycoprotein B Market Value Comparison by Application (2024-2030) & (US$ Million)
    Figure 11. Global Human Cytomegalovirus Envelope Glycoprotein B Market Share by Application in 2023 & 2030
    Figure 12. Infectious Disease
    Figure 13. Oncology
    Figure 14. Women's Health
    Figure 15. Others
    Figure 16. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size (2019-2030) & (US$ Million)
    Figure 18. Global Human Cytomegalovirus Envelope Glycoprotein B Sales (2019-2030) & (K Pcs)
    Figure 19. Global Human Cytomegalovirus Envelope Glycoprotein B Average Price (USD/Pcs) & (2019-2030)
    Figure 20. Human Cytomegalovirus Envelope Glycoprotein B Report Years Considered
    Figure 21. Human Cytomegalovirus Envelope Glycoprotein B Sales Share by Manufacturers in 2023
    Figure 22. Global Human Cytomegalovirus Envelope Glycoprotein B Revenue Share by Manufacturers in 2023
    Figure 23. The Global 5 and 10 Largest Human Cytomegalovirus Envelope Glycoprotein B Players: Market Share by Revenue in 2023
    Figure 24. Human Cytomegalovirus Envelope Glycoprotein B Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
    Figure 25. Global Human Cytomegalovirus Envelope Glycoprotein B Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Figure 26. North America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2019-2030)
    Figure 27. North America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2019-2030)
    Figure 28. U.S. Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 29. Canada Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 30. Europe Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2019-2030)
    Figure 31. Europe Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2019-2030)
    Figure 32. Germany Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 33. France Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 34. U.K. Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 35. Italy Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 36. Russia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 37. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Region (2019-2030)
    Figure 38. Asia Pacific Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Region (2019-2030)
    Figure 39. China Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 40. Japan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 41. South Korea Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 42. India Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 43. Australia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 44. Taiwan Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 45. Indonesia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 46. Thailand Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 47. Malaysia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 48. Philippines Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 49. Latin America Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2019-2030)
    Figure 50. Latin America Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2019-2030)
    Figure 51. Mexico Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 52. Brazil Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 53. Argentina Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 54. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Sales Market Share by Country (2019-2030)
    Figure 55. Middle East & Africa Human Cytomegalovirus Envelope Glycoprotein B Revenue Market Share by Country (2019-2030)
    Figure 56. Turkey Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 58. U.A.E Human Cytomegalovirus Envelope Glycoprotein B Revenue Growth Rate (2019-2030) & (US$ Million)
    Figure 59. Global Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Type (2019-2030)
    Figure 60. Global Revenue Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Type (2019-2030)
    Figure 61. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) by Type (2019-2030)
    Figure 62. Global Sales Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Application (2019-2030)
    Figure 63. Global Revenue Market Share of Human Cytomegalovirus Envelope Glycoprotein B by Application (2019-2030)
    Figure 64. Global Human Cytomegalovirus Envelope Glycoprotein B Price (USD/Pcs) by Application (2019-2030)
    Figure 65. Human Cytomegalovirus Envelope Glycoprotein B Value Chain
    Figure 66. Human Cytomegalovirus Envelope Glycoprotein B Production Process
    Figure 67. Channels of Distribution (Direct Vs Distribution)
    Figure 68. Distributors Profiles
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Mumps Vaccine Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-19C11605
Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Monkeypox Vaccine Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-17F11344
Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Coxsackie Virus A16 Nucleic Acid Detection Reagent Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20I10733
Wed Jun 12 00:00:00 UTC 2024

Add to Cart

Global Hepatitis B Virus Nucleic Acid Detection Kit Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-38W10575
Wed Jun 12 00:00:00 UTC 2024

Add to Cart